Literature DB >> 29175520

Alzheimer's disease-associated ubiquitin mutant Ubb+1: Properties of the carboxy-terminal domain and its influence on biomolecular interactions.

Francesca Munari1, Andrea Bortot1, Michael Assfalg1, Mariapina D'Onofrio2.   

Abstract

Ubb+1, a ubiquitin (Ub) mutant protein originating from misreading of the Ub B gene, is found accumulated in brain tissues of Alzheimer's disease patients. The mutant attracts strong interest due to its possible participation in the molecular events leading to neurodegeneration. Ubb+1 is composed of the globular domain of Ub, linked to a 19-residue C-terminal peptide. Based on NMR relaxation and solvent accessibility measurements we obtained new insight into the molecular properties of Ubb+1. We further determined the thermal stability of Ubb+1 in the monomeric form, and in Lys48- and Lys63-linked dimers. Finally, we explored the influence of the C-terminal fragment on the interactions of Ubb+1 with an isolated UBA2 domain and with membrane mimics. Our data indicate that the C-terminal fragment of Ubb+1 is overall highly flexible, except for a short stretch which appears less solvent-exposed. While influencing the hydrodynamic properties of the globular domain, the fragment does not establish long-lived interactions with the globular domain. It results that the structure and stability of Ub are minimally perturbed by the peptide extension. However, binding to UBA2 and to membrane mimics are both affected, exemplifying possible changes in biomolecular recognition experienced by the disease-associated Ubb+1 compared to the wild-type protein.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Alzheimer’s disease; NMR spectroscopy; Protein dynamics; Solvent accessibility; Ubb(+1); Ubiquitin

Mesh:

Substances:

Year:  2017        PMID: 29175520     DOI: 10.1016/j.ijbiomac.2017.11.121

Source DB:  PubMed          Journal:  Int J Biol Macromol        ISSN: 0141-8130            Impact factor:   6.953


  6 in total

1.  Semisynthetic Modification of Tau Protein with Di-Ubiquitin Chains for Aggregation Studies.

Authors:  Francesca Munari; Carlo Giorgio Barracchia; Francesca Parolini; Roberto Tira; Luigi Bubacco; Michael Assfalg; Mariapina D'Onofrio
Journal:  Int J Mol Sci       Date:  2020-06-20       Impact factor: 5.923

2.  Reorientational Dynamics of Amyloid-β from NMR Spin Relaxation and Molecular Simulation.

Authors:  Nasrollah Rezaei-Ghaleh; Giacomo Parigi; Markus Zweckstetter
Journal:  J Phys Chem Lett       Date:  2019-06-06       Impact factor: 6.475

Review 3.  The Dose-Dependent Pleiotropic Effects of the UBB+1 Ubiquitin Mutant.

Authors:  Katarzyna Banasiak; Natalia A Szulc; Wojciech Pokrzywa
Journal:  Front Mol Biosci       Date:  2021-03-26

4.  Mendelian randomization integrating GWAS and mQTL data identified novel pleiotropic DNA methylation loci for neuropathology of Alzheimer's disease.

Authors:  Di Liu; Youxin Wang; Huiquan Jing; Qun Meng; Jingyun Yang
Journal:  Neurobiol Aging       Date:  2020-10-01       Impact factor: 4.673

5.  Screening and Identification of Potential Peripheral Blood Biomarkers for Alzheimer's Disease Based on Bioinformatics Analysis.

Authors:  Xin Wang; Lantao Wang
Journal:  Med Sci Monit       Date:  2020-08-19

6.  A Network Pharmacology Approach to Reveal the Underlying Mechanisms of Paeonia lactiflora Pall. On the Treatment of Alzheimer's Disease.

Authors:  Qiang Zeng; Longfei Li; Yu Jin; Zongzheng Chen; Lihong Duan; Meiqun Cao; Min Ma; Zhengzhi Wu
Journal:  Evid Based Complement Alternat Med       Date:  2019-11-16       Impact factor: 2.629

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.